Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May;31(2):425-45.
doi: 10.1016/j.ncl.2013.02.004. Epub 2013 Mar 15.

Diabetic neuropathy part 1: overview and symmetric phenotypes

Affiliations
Review

Diabetic neuropathy part 1: overview and symmetric phenotypes

Mamatha Pasnoor et al. Neurol Clin. 2013 May.

Abstract

Diabetes is the most common cause of neuropathy in United States and neuropathies are the most common complication of diabetes mellitus, affecting up to 50% of patients with type 1 and type 2 diabetes mellitus. Symptoms usually include numbness, tingling, pain, and weakness. Dizziness with postural changes can be seen with autonomic neuropathy. Metabolic, vascular, and immune theories have been proposed for the pathogenesis of diabetic neuropathy. Axonal damage and segmental demyelination can be seen with diabetic neuropathies. Management of diabetic neuropathy should begin at the initial diagnosis of diabetes and mainly requires tight and stable glycemic control.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Spectrum of possible pathophysiologic causes of various diabetic neuropathies
Figure 2
Figure 2
Patient’s weight over time and the onset of neuropathic pain and initiation of diabetic therapy. +=Initiation of oral hypoglycemic; *=initiation of insulin; ↓=onset of pain

Similar articles

Cited by

References

    1. Barohn RJ. Diabetic Neuropathy. Decision Making in Pain Management. (Second Edition) 2006:82–83.
    1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197. - PubMed
    1. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population ages 20–74. Diabetes. 1987;36:523–534. - PubMed
    1. Dyck PH, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology. 1993;43:817–824. - PubMed
    1. Centers for Disease Control and Prevention. National Fact Sheet. Atlanta, GA: CDC, USHHS; 2011. [Accessed on December 1, 2012]. 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.

MeSH terms